Assignee

Magnolia Medical Technologies, Inc.

Patents = 80

Trademarks = 10

Forward Citations = 2,202

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

19 inventors (with patents filed for the assignee):

Magnolia Medical Technologies, Inc. is a medical device company dedicated to improving the accuracy and reliability of diagnosing bloodstream infections. They have developed a unique Steripath Gen2 blood collection system that significantly reduces the frequency of blood culture contamination, leading to more accurate and timely test results. Magnolia's innovative solutions aim to reduce the occurrence of false-positive results and improve patient outcomes in the field of infectious disease diagnostics.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com